Crohn’s & Colitis Australia (CCA) provides support programs and advocacy for the health and wellbeing of over 85,000 people living with inflammatory bowel diseases (IBD). As part of our mission to improve the lives of those with Crohn’s disease and ulcerative colitis, in 2013 we commissioned PricewaterhouseCoopers Australia (PwC) to update existing IBD national health economic and prevalence data.
The report, Improving Inflammatory Bowel Disease Care across Australia, identified significant geographical variations in access to quality care, and found that the current model of care was inequitable and increasing in cost. It suggested that improvements in the model of care could have benefits for the quality of care individuals receive and cost savings to the healthcare system.
In 2014 CCA obtained the endorsement of the peak learned bodies representing key health stakeholders to implement the Quality of Care Program. In its first two years, kickstarted by an Australian Government grant, the program undertook to develop the Australian IBD Standards and to perform a national audit of the organisation and provision of IBD services in Australia. After completing these projects successfully CCA’s ongoing commitment to the program was defined.
Aim of the IBD Quality of Care Program
To influence the organisation, resources, and provision of health care to promote better, person- centred outcomes for people living with IBD.
Since then CCA and its partners have completed important projects to improve outcomes for people living with IBD. These include two surveys on the patient experience of care and the preparation of an Australian IBD National Action Plan on behalf of the Australian Government.
Learn more about: